Medication Total (n=1,537) CHD diagnosed (n=1,266) CHD not diagnosed (n=152)
RAS blocker 1,087 (70.7%) 923 (72.9%) 77 (50.7%)
Beta blocker 1,086 (70.7%) 935 (73.9%) 75 (49.3%)
Aggregation inhibitor 881 (57.3%) 769 (60.7%) 44 (28.9%)
Nitrate (short-acting) 502 (32.7%) 417 (32.9%) 48 (31.6%)
Calcium antagonist 348 (22.6%) 287 (22.7%) 30 (19.7%)
Nitrate (long-acting) 353 (23.0%) 308 (24.3%) 20 (13.2%)
Table 3: Concomitant medication–FAS, FAS: Full analysis set. Information on CHD status was missing in 119 patients.